Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Are Hedge Funds Doing With Yuanbao Yb Stock Price At 18.26 Down 1.83 20260328 What Is The Future Of Dynamix Ethm Stock Price At 10.49 Down 0.05 20260410 Will Jack In Jack Stock Outperform Peers Jack Q4 Earnings Misses Estimates By 0.06 20260410 1 Will Nixxy Nixx Stock Fall Further Price At 0.80 Up 0.90 20260328 Cnobp Stock Analysis Connectone Bancorp Series A Preferred Up 0.39 Pct To 24.64 Stable Yield Outlook 20260403 1 VRSN VeriSign Inc posts 43 percent Q4 2025 EPS miss shares edge slightly higher after quarterly results NMFCZ New notes slip as Q1 earnings fall short by 2 percent shares dip slightly How Kingsway KFS stacks up against the best in its class Bullish Sentiment 20260508 Is LifeMD LFMD stock hiding in plain sight Eye on Rally 20260508 FC Income DFP Stock Is It Worth Entering Now Slow Grind 20260418 MP Materials Q1 revenue rises 10 yearoveryear but MP shares slide 246 on wider loss Why Concentrix CNXC could deliver where others fall short Trend Weakens 20260508 XCUR Exicure Inc posts wider than projected Q1 2022 loss while its shares climb on positive investor sentiment GDRX GoodRx Holdings Inc drops 34 today after Q4 2025 EPS narrowly falls short of analyst expectations Is Kirby Corporation KEX stock attractive today Mini Rally 20260420 ON ON Stock Is It Breaking Key Structure In Focus 20260420 IBO Impact BioMedical highlights promising preclinical trial progress in its latest quarterly earnings release Is CohenSteers CNS stock weak today Cohen and Steers posts 34 EPS miss vs analyst estimates Illumina Inc ILMN APH Amphenol tops Q4 2025 EPS estimates on 517 percent revenue growth yet shares dip 25 percent today PI Impinj reports narrow Q4 2025 earnings miss shares tick higher as investors brush off mild revenue dip Market Recap SP 500 dips modestly as major US indices end mixed session Regeneron Pharmaceuticals REGN Bullish LongTerm Outlook Supported by Diversified Portfolio and Pipeline Expansion for Discretionary Investors KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss even as shares edge slightly higher KF Korea Fund leadership targets expanded Korean semiconductor exposure to drive future portfolio performance